Altivera Medical names Brian Brinson EVP of sales

Altivera Medical said Oct. 4, 2026, that Army veteran Brian Brinson has joined the MedTech company as executive vice president of sales. The hire is aimed at accelerating growth in orthopedic, post-surgical recovery, rehabilitation and pain management technologies as Altivera expands its provider network.

Why it matters: - Altivera Medical is adding a sales leader with experience in both pain management and orthopedics, two core areas for the company. - The hire comes as Altivera expands its provider network and looks to reach more patients recovering from surgery or living with chronic pain. - The role is central to scaling commercial execution while maintaining regulatory compliance and clinical integrity.

What happened: - Altivera Medical Holdings LLC appointed Brian Brinson as executive vice president of sales on Oct. 4, 2026. - Brinson is an Army veteran who began his career as an officer in the U.S. Army before moving into medical device sales. - His background includes sales leadership roles at DePuy Synthes, a Johnson & Johnson company, Abbott and Onkos Surgical. - At Abbott, Brinson led the neuromodulation business focused on pain management. - At Onkos Surgical, Brinson led commercial efforts in surgical oncology and complex orthopedic solutions.

The details: - Altivera said Brinson will lead the national sales organization and oversee strategy and execution as the company scales. - The company said Brinson’s experience across pain management and orthopedics aligns with two of Altivera’s strategic priorities. - Altivera said the sales role will support growth across orthopedic and post-surgical recovery, rehabilitation and pain management technologies. - Brinson said he was drawn to Altivera by the results he has seen with NexWave and its impact on patient recovery. - Brinson said he wants to build a sales organization centered on patient outcomes and provider needs. - Altivera said it is welcoming new prescribers while reengaging providers who have used its technologies before. - Altivera said it is extending the reach of its NMES and IFC therapies to more patients. - Altivera said its approach remains grounded in regulatory compliance and clinical integrity.

Between the lines: - The appointment signals a push to pair clinical credibility with commercial expansion. - Brinson’s mix of military leadership and MedTech sales may appeal to providers and customers that value disciplined execution. - Altivera is also signaling that growth will be paired with compliance, not just faster sales.

What's next: - Brinson is expected to help expand Altivera’s sales footprint and support broader adoption of its recovery and pain relief technologies. - Altivera will likely keep building its provider base while converting former users back into active prescribers. - The company’s next phase depends on turning sales leadership into measurable growth across its product portfolio.

The bottom line: - Altivera is betting that an experienced MedTech sales executive can help scale its recovery and pain management businesses faster.